title: New cholesterol drugs are overpriced, independent analysis finds.
authors.affiliation: Seattle.
authors.forename: Michael
authors.initials: M
authors.lastname: McCarthy
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000191:economics*; D061067:Antibodies, Monoclonal, Humanized; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000191:economics*; D050197:Atherosclerosis / Q000188:drug therapy* / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000924:Anticholesteremic Agents; C577155:evolocumab; C571059:alirocumab